IntelGenx Technologies Corp.
IGX
Clasificación en acciones
#28121
IntelGenx Technologies Corp. is a pharmaceutical drug delivery enterprise... IntelGenx Technologies Corp. is a pharmaceutical drug delivery enterprise focused on the creation and manufacturing of advanced oral thin film products. The company's diverse product pipeline encompasses various oral film formulations designed to address a wide spectrum of medical conditions. These include INT0008/2008, a Rizatriptan film for migraine management; INT0046/2018 for adult applications; INT0007/2006, an oral film targeting erectile dysfunction; INT0043/2015, a montelukast-based film for Alzheimer's disease; INT0027/2011, intended for opioid addiction treatment; INT0010/2006, addressing neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, formulated for schizophrenia or bipolar I disorder; and INT0048/2020, developed for veterinary health. Additionally, IntelGenx is actively developing other candidates identified as INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has established strategic partnerships, including a comprehensive licensing, development, and supply agreement with Tilray, Inc., alongside a development pact with Cynapsus Therapeutics Inc. Founded in 2003, IntelGenx Technologies Corp. is headquartered in Montreal, Canada.
Precio por acción
$0.17446996
Última sincronización: 2024-06-11
Capitalización bursátil
$26.97M
Cambio (1 día)
-0.57%
Cambio (1 año)
2.63%
País
CA
Comercio IntelGenx Technologies Corp. (IGX)
Categoría
Healthcare
Número de acciones en circulación de IntelGenx Technologies Corp. (IGX)
Número de acciones en circulación al March 2024: 174.66M
Según los últimos informes financieros y el precio de las acciones de IntelGenx Technologies Corp., el número actual de acciones en circulación es 174.66M. Al final de December 2022, la empresa tenía 164.75M acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de IntelGenx Technologies Corp. (IGX) desde 2003 hasta 2026
Acciones en circulación al final de cada año
| Año | Acciones en circulación | Cambiar |
|---|---|---|
| 2026 (TTM) | 174.66M | 0.00% |
| 2023 | 174.65M | 6.01% |
| 2022 | 164.75M | 20.25% |
| 2021 | 137.00M | 26.34% |
| 2020 | 108.44M | 15.95% |
| 2019 | 93.53M | 26.18% |
| 2018 | 74.12M | 12.05% |
| 2017 | 66.15M | 3.43% |
| 2016 | 63.96M | 0.68% |
| 2015 | 63.52M | 0.54% |
| 2014 | 63.18M | 16.95% |
| 2013 | 54.02M | 8.84% |
| 2012 | 49.64M | 13.49% |
| 2011 | 43.74M | 23.81% |
| 2010 | 35.33M | 44.02% |
| 2009 | 24.53M | 24.78% |
| 2008 | 19.66M | 22.53% |
| 2007 | 16.04M | 11.91% |
| 2006 | 14.34M | 30.42% |
| 2005 | 10.99M | 632.73% |
| 2004 | 1.50M | 0.00% |
| 2003 | 1.50M | 0.00% |
Acciones en circulación de empresas similares o competidores
| Empresa | Acciones en circulación | Diferencia | País |
|---|---|---|---|
| 253.90M | 45.37% |
US
|
|
| 396.00M | 126.73% |
US
|
|
| 478.91M | 174.20% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -64.40% |
NL
|
